Plain-English translation of NCT06643767 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Breast Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is evaluating a new breast examination method called Bexa Breast Examination (BBE) as a way to screen for breast cancer. The Bexa exam uses light pressure on the breast and may offer a gentler, less painful alternative to mammography. Researchers want to see if this new method can effectively detect breast cancer early, especially for women who avoid or cannot have mammograms.
Current mammography has limitations: it can be painful, involves radiation exposure, misses some cancers, and produces false alarms. Many women—especially younger women and women of color—skip mammography screening altogether. This trial aims to offer a new screening option that might be more comfortable and accessible.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will complete the new Bexa Breast Examination as part of your screening visit. The exam uses gentle pressure on your breast and takes a short time to complete. You may also have an ultrasound and will still receive your regular mammogram screening; researchers will compare how well each method detects breast abnormalities.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
United States
Sponsor
Sure, Inc.
Collaborators
Hendrick Medical Center
Enrollment target
~500 participants
Started
October 2024
Primary completion
February 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
30 Years – 75 Years
Sex
Female only
Last updated on clinicaltrials.gov in October 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Danielle Goss, MPH, MHA, CHRC, HEC-C
Hendrick Health
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.